Journal
TOXICOLOGY IN VITRO
Volume 79, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tiv.2021.105297
Keywords
circPVT1 miR-199a-5p; Senescence/aging; SIRT1; Tendon stem/progenitor cells
Categories
Funding
- National Natural Science Foundation of China [81874012]
Ask authors/readers for more resources
This study analyzed the involvement of circular RNA (circRNA) PVT1 (circPVT1) in the senescence of tendon stem/progenitor cells (TSPCs). It was found that circPVT1 suppresses TSPC senescence, at least in part, by upregulating the miR-199a-5p-SIRT1 signaling axis. These findings suggest circPVT1 as a potential therapeutic target for reducing tendon senescence.
Tendon stem/progenitor cell (TSPC) senescence can lead to age-dependent tendon maladies and undermines both tendon repair and replacement capacity in humans. The mechanisms underlying TSPC senescence and sensitivity to adverse factors are complicated. In this study, we analyzed involvement of the circular RNA (circRNA) PVT1 (circPVT1) in TSPC senescence. circPVT1 expression was found to be significantly diminished in human TSPCs under prolonged in vitro culture. Accordingly, circPVT1 knockdown promoted senescence progression and suppressed self renewal, migration, and tenogenic differentiation of TSPCs. Furthermore, we found that circPVT1 directly targets microRNA (miR)-199a-5p thereby attenuating its negative regulation of SIRT1 expression. Either miR-199a-5p inhibition or SIRT1 overexpression attenuated the senescence-boosting effect of circPVT1 knockdown, implying that circPVT1 suppresses TSPC senescence in part by upregulating the miR-199a5p-SIRT1 signaling axis. Our findings conclusively explain the major roles of circPVT1 in TSPC senescence regulation; circPVT1 is a novel potential therapeutic target for reducing tendon senescence.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available